Development of Folic Acid-Conjugated and Methylene Blue-Adsorbed Au@TNA Nanoparticles for Enhanced Photodynamic Therapy of Bladder Cancer Cells
Photodynamic therapy (PDT) is a promising treatment for malignancy. However, the low molecular solubility of photosensitizers (PSs) with a low accumulation at borderline malignant potential lesions results in the tardy and ineffective management of recurrent urothelial carcinoma. Herein, we used tan...
Main Authors: | Che-Wei Hsu, Nai-Chi Cheng, Mei-Yi Liao, Ting-Yu Cheng, Yi-Chun Chiu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Nanomaterials |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-4991/10/7/1351 |
Similar Items
-
In Vitro Selection of an ATP-Binding TNA Aptamer
by: Li Zhang, et al.
Published: (2020-09-01) -
Submicron vaterite particles, loaded with porphyrazine photosensitizer for photodynamic therapy of bladder carcinoma cells
by: Shestakova, Lydia N., et al.
Published: (2023-03-01) -
Intraoperative photodynamic therapy of bladder cancer with alasens (results of multicenter trial)
by: E. V. Filonenko, et al.
Published: (2014-12-01) -
Correction: Hsu et al. Development of Folic Acid-Conjugated and Methylene Blue-Adsorbed Au@TNA Nanoparticles for Enhanced Photodynamic Therapy of Bladder Cancer Cells. <i>Nanomaterials</i> 2020, <i>10</i>, 1351
by: Che-Wei Hsu, et al.
Published: (2023-08-01) -
Secreted protein TNA: a promising biomarker for understanding the adipose-bone axis and its impact on bone metabolism
by: Shaobo Wu, et al.
Published: (2024-09-01)